imo myer's greatest asset is its brand name.
they need to build on that, private label everything sell quality dispose of the cheap stuff which goes out of fashion and doesnt last
- Forums
- ASX - By Stock
- MYR
- Ann: Myer Half Year Results (1H2018)
Ann: Myer Half Year Results (1H2018), page-150
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MYR (ASX) to my watchlist
(20min delay)
|
|||||
Last
79.8¢ |
Change
-0.003(0.31%) |
Mkt cap ! $665.4M |
Open | High | Low | Value | Volume |
80.5¢ | 80.5¢ | 78.5¢ | $738.2K | 925.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
32 | 76296 | 79.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
80.0¢ | 109040 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
32 | 74190 | 0.795 |
14 | 59794 | 0.790 |
9 | 57035 | 0.785 |
8 | 52364 | 0.780 |
7 | 125751 | 0.775 |
Price($) | Vol. | No. |
---|---|---|
0.800 | 108382 | 12 |
0.805 | 78738 | 7 |
0.810 | 61912 | 6 |
0.815 | 123889 | 4 |
0.820 | 68133 | 13 |
Last trade - 14.26pm 15/07/2024 (20 minute delay) ? |
Featured News
MYR (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online